1 in 31: What the New Autism Prevalence Numbers Mean for Your Practice

Every two years, the CDC's Autism and Developmental Disabilities Monitoring Network publishes prevalence estimates that reshape the conversation. The 2022 data — released April 2025 — pushed the number to 1 in 31. In a single generation, autism prevalence has increased fivefold. In 2000, it was 1 in 150. That number now looks almost quaint.

The Curve Is Not Flattening

The trajectory matters more than the snapshot. From 1 in 150 to 1 in 88 to 1 in 44 to 1 in 36 — each cycle brought a new round of the same debate: is this a real increase or better detection? The honest answer remains: both. Broadened diagnostic criteria (DSM-5 folded Asperger's into ASD), improved screening tools, greater public awareness, and expanded surveillance infrastructure all contribute. But the slope of the curve has not decelerated. From 2020 to 2022, prevalence rose 22% across sites with comparable data. That is not a reclassification artifact. Something beyond detection is happening, and we do not yet know what.

The Racial Equity Story

For two decades, autism was disproportionately identified in White children. Black, Hispanic, and Asian children were consistently underdiagnosed — not because autism was less common in these populations, but because access to evaluation was unequal. The 2022 data marks a turning point. Black children (36.6 per 1,000), Asian/Pacific Islander children (38.2), and Hispanic children (33.0) now all exceed White prevalence (27.7). American Indian/Alaska Native children show 37.5 per 1,000.

This is not a sudden increase in autism among minority children. It is the delayed correction of decades of diagnostic inequality. Community-based screening programs, culturally adapted evaluation tools, and the expansion of school-based identification have started closing the gap. The clinical significance is substantial: these children now have access to earlier intervention. But the pipeline is strained. More diagnoses require more services, and the workforce to deliver them was already insufficient.

California: A Preview of National Trends

California's prevalence — 53.1 per 1,000, roughly 1 in 19 — is the highest in the network and likely a preview of where other states will arrive as their identification infrastructure matures. California has invested in the Get SET Early model, training hundreds of pediatricians to screen and refer as early as possible. It also has a statewide regional center system providing evaluations and service coordination. The result: more children identified, earlier. Whether other states can replicate this infrastructure under tighter budgets is an open question.

What This Means for Clinicians

The clinical implications are concrete. If 3.2% of children are autistic, every clinician in general mental health practice — not just specialists — will encounter them regularly. Anxiety referrals that are actually autistic burnout. Depression that is actually social isolation from masking. ADHD that is actually executive function differences in an autistic profile. The differential diagnosis workload increases for everyone.

Adult referrals will surge in parallel. If 1 in 31 children is autistic today, a comparable proportion of adults went undiagnosed in an era when the number was 1 in 150. These adults are now entering clinics with mood disorders, relationship difficulties, and occupational problems — undiagnosed autism is the substrate, not the presenting complaint. The workforce is not ready for this volume. Waitlists for adult autism evaluation already stretch to 12-18 months in most urban centers.

Every clinician who conducts intake assessments needs baseline competency in recognizing autistic presentations. This is no longer a subspecialty concern. It is general practice.